Access the full text.
Sign up today, get DeepDyve free for 14 days.
Ç. Soydal, O. Kucuk, S. Bilgiç, E. Íbiş (2015)
Radioembolization with 90Y resin microspheres for intrahepatic cholangiocellular carcinoma: prognostic factorsAnnals of Nuclear Medicine, 30
E. Garin, Y. Rolland, J. Edeline, N. Icard, L. Lenoir, S. Laffont, H. Mesbah, Mathias Breton, L. Sulpice, K. Boudjema, T. Rohou, J. Raoul, B. Clément, E. Boucher (2015)
Personalized Dosimetry with Intensification Using 90Y-Loaded Glass Microsphere Radioembolization Induces Prolonged Overall Survival in Hepatocellular Carcinoma Patients with Portal Vein ThrombosisThe Journal of Nuclear Medicine, 56
Patients Previously Treated with Selective Internal Radiation Therapy with Yttrium-90
Radioembolization for Unresectable 400
Tamer Shaker, Chloe Chung, M. Varma, M. Doherty, Andrea Wolf, M. Chung, M. Assifi (2018)
Is there a role for Ytrrium-90 in the treatment of unresectable and metastatic intrahepatic cholangiocarcinoma?American journal of surgery, 215 3
A. Cucchetti, A. Cappelli, C. Mosconi, J. Zhong, M. Cescon, A. Pinna, R. Golfieri (2017)
Improving patient selection for selective internal radiation therapy of intra‐hepatic cholangiocarcinoma: A meta‐regression studyLiver International, 37
J. Everhart, C. Ruhl (2009)
Burden of digestive diseases in the United States Part III: Liver, biliary tract, and pancreas.Gastroenterology, 136 4
R. Kloeckner, C. Ruckes, K. Kronfeld, M. Wörns, A. Weinmann, P. Galle, H. Lang, G. Otto, W. Eichhorn, M. Schreckenberger, C. Dueber, M. Pitton (2014)
Selective internal radiotherapy (SIRT) versus transarterial chemoembolization (TACE) for the treatment of intrahepatic cholangiocellular carcinoma (CCC): study protocol for a randomized controlled trialTrials, 15
O. Hyder, J. Marsh, R. Salem, E. Petre, S. Kalva, E. Liapi, D. Cosgrove, D. Neal, I. Kamel, A. Zhu, C. Sofocleous, J. Geschwind, T. Pawlik (2013)
Intra-arterial Therapy for Advanced Intrahepatic Cholangiocarcinoma: A Multi-institutional AnalysisAnnals of Surgical Oncology, 20
J. Valle, H. Wasan, D. Palmer, D. Cunningham, A. Anthoney, A. Maraveyas, S. Madhusudan, T. Iveson, S. Hughes, S. Pereira, M. Roughton, J. Bridgewater (2010)
Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer.The New England journal of medicine, 362 14
A. Lamarca, P. Ross, H. Wasan, R. Hubner, M. McNamara, A. Lopes, P. Manoharan, D. Palmer, J. Bridgewater, J. Valle (2019)
Advanced intrahepatic cholangiocarcinoma: post-hoc analysis of the ABC-01, -02 and -03 clinical trials.Journal of the National Cancer Institute
A. Saxena, L. Bester, T. Chua, F. Chu, David Morris (2010)
Yttrium-90 Radiotherapy for Unresectable Intrahepatic Cholangiocarcinoma: A Preliminary Assessment of This Novel Treatment OptionAnnals of Surgical Oncology, 17
J. Edeline, M. Benabdelghani, A. Bertaut, J. Watelet, P. Hammel, J. Joly, K. Boudjema, L. Fartoux, K. Bouhier‐Leporrier, J. Jouve, R. Faroux, V. Guérin-Meyer, J. Kurtz, E. Assenat, J. Seitz, I. Baumgaertner, D. Tougeron, C. Fouchardière, C. Lombard-Bohas, E. Boucher, T. Stanbury, C. Louvet, D. Malka, J. Phelip (2019)
Gemcitabine and Oxaliplatin Chemotherapy or Surveillance in Resected Biliary Tract Cancer (PRODIGE 12-ACCORD 18-UNICANCER GI): A Randomized Phase III Study.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 37 8
L. Beuzit, J. Edeline, V. Brun, M. Ronot, A. Guillygomarc’h, K. Boudjema, Y. Gandon, E. Garin, Y. Rolland (2016)
Comparison of Choi criteria and Response Evaluation Criteria in Solid Tumors (RECIST) for intrahepatic cholangiocarcinoma treated with glass-microspheres Yttrium-90 selective internal radiation therapy (SIRT).European journal of radiology, 85 8
Retrospective Analysis of Safety Following Hepatic Resection or Transplantation
S. Mouli, Khairuddin Memon, Talia Baker, A. Benson, M. Mulcahy, Ramona Gupta, R. Ryu, R. Salem, R. Lewandowski (2013)
Yttrium-90 radioembolization for intrahepatic cholangiocarcinoma: safety, response, and survival analysis.Journal of vascular and interventional radiology : JVIR, 24 8
J. Valle, I. Borbath, Shahid Khan, F. Huguet, T. Gruenberger, D. Arnold (2016)
Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Annals of oncology : official journal of the European Society for Medical Oncology, 27 suppl 5
R. Salem, R. Lewandowski, V. Gates, C. Nutting, R. Murthy, S. Rose, M. Soulen, J. Geschwind, L. Kulik, Y. Kim, C. Spreafico, M. Maccauro, L. Bester, Daniel Brown, R. Ryu, D. Sze, W. Rilling, Kent Sato, B. Sangro, J. Bilbao, T. Jakobs, S. Ezziddin, S. Kulkarni, A. Kulkarni, David Liu, D. Valenti, P. Hilgard, G. Antoch, S. Muller, H. Alsuhaibani, M. Mulcahy, M. Burrel, M. Real, S. Spies, A. Esmail, J. Raoul, E. Garin, Mathew Johnson, A. Benson, Ricky Sharma, H. Wasan, B. Lambert, Khairuddin Memon, A. Kennedy, A. Riaz (2011)
Research reporting standards for radioembolization of hepatic malignancies.Journal of vascular and interventional radiology : JVIR, 22 3
R. Shridhar, J. Frakes, B. Yue, R. Kim, G. Springett, B. Arslan, Junsung Choi, B. Kis, T. Yeatman, K. Meredith, S. Hoffe (2017)
Phase II study of first-line radioembolization with yttrium-90 glass microspheres for intrahepatic cholangiocarcinoma.Journal of Clinical Oncology, 35
J. Camacho, N. Kokabi, M. Xing, H. Prajapati, B. El-Rayes, Hyun Kim (2014)
Modified response evaluation criteria in solid tumors and European Association for The Study of the Liver criteria using delayed-phase imaging at an early time point predict survival in patients with unresectable intrahepatic cholangiocarcinoma following yttrium-90 radioembolization.Journal of vascular and interventional radiology : JVIR, 25 2
Prognostic 395 Factors in Overall Survival of Patients with Unresectable Intrahepatic 396
T. Hong, J. Wo, B. Yeap, E. Ben-Josef, E. McDonnell, L. Blaszkowsky, E. Kwak, Jill Allen, Jeffrey Clark, L. Goyal, Janet Murphy, M. Javle, J. Wolfgang, L. Drapek, R. Arellano, H. Mamon, J. Mullen, Sam Yoon, K. Tanabe, C. Ferrone, D. Ryan, T. Delaney, C. Crane, A. Zhu (2016)
Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 34 5
E. Garin, E. Garin, L. Lenoir, L. Lenoir, J. Edeline, S. Laffont, H. Mesbah, P. Porée, Laurent Sulpice, K. Boudjema, K. Boudjema, M. Mesbah, A. Guillygomarc'h, E. Quehen, M. Pracht, J.-L. Raoul, Bruno Clément, Y. Rolland, E. Boucher (2013)
Boosted selective internal radiation therapy with 90Y-loaded glass microspheres (B-SIRT) for hepatocellular carcinoma patients: a new personalized promising conceptEuropean Journal of Nuclear Medicine and Molecular Imaging, 40
C. Mosconi, A. Gramenzi, S. Ascanio, A. Cappelli, M. Renzulli, C. Pettinato, G. Brandi, F. Monari, A. Cucchetti, F. Trevisani, R. Golfieri (2016)
Yttrium-90 radioembolization for unresectable/recurrent intrahepatic cholangiocarcinoma: a survival, efficacy and safety studyBritish Journal of Cancer, 115
D. Al‐Adra, R. Gill, S.J. Axford, Xinzhe Shi, N. Kneteman, S. Liau (2015)
Treatment of unresectable intrahepatic cholangiocarcinoma with yttrium-90 radioembolization: A systematic review and pooled analysisEuropean Journal of Surgical Oncology, 41
A. Custodio, J. Moreno-Rubio, J. Aparicio, J. Gallego-Plazas, R. Yayá, J. Maurel, O. Higuera, E. Burgos, D. Ramos, A. Calatrava, E. Andrada, R. López, V. Moreno, R. Madero, P. Cejas, J. Feliu (2014)
Cisplatin and gemcitabine for advanced biliary tract cancer : a meta-analysis of two randomised trials
(2013)
World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.JAMA, 310 20
R. Cook, B. Dickens, M. Fathalla (2003)
World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.The Journal of the American College of Dentists, 81 3
N. Swinburne, D. Biederman, C. Besa, N. Tabori, A. Fischman, Rahul Patel, F. Nowakowski, G. Gunasekaran, M. Schwartz, R. Lookstein, Edward Kim (2017)
Radioembolization for Unresectable Intrahepatic Cholangiocarcinoma: Review of Safety, Response Evaluation Criteria in Solid Tumors 1.1 Imaging Response and Survival.Cancer biotherapy & radiopharmaceuticals, 32 5
E. Garin, Y. Rolland, M. Pracht, S. Sourd, S. Laffont, H. Mesbah, Laure-Anne Haumont, L. Lenoir, T. Rohou, V. Brun, J. Edeline (2016)
High impact of macroaggregated albumin‐based tumour dose on response and overall survival in hepatocellular carcinoma patients treated with 90Y‐loaded glass microsphere radioembolizationLiver International, 37
J. Valle, J. Furuse, M. Jitlal, S. Beare, N. Mizuno, H. Wasan, J. Bridgewater, T. Okusaka (2014)
Cisplatin and gemcitabine for advanced biliary tract cancer: a meta-analysis of two randomised trials.Annals of oncology : official journal of the European Society for Medical Oncology, 25 2
L. Filippi, G. Pelle, R. Cianni, F. Scopinaro, O. Bagni (2015)
Change in total lesion glycolysis and clinical outcome after (90)Y radioembolization in intrahepatic cholangiocarcinoma.Nuclear medicine and biology, 42 1
Personalized dosimetry with intensification using 481
E. Garin, L. Lenoir, Y. Rolland, S. Laffont, M. Pracht, H. Mesbah, P. Porée, V. Ardisson, P. Bourguet, B. Clément, E. Boucher (2011)
Effectiveness of quantitative MAA SPECT/CT for the definition of vascularized hepatic volume and dosimetric approach: phantom validation and clinical preliminary results in patients with complex hepatic vascularization treated with yttrium-90-labeled microspheresNuclear Medicine Communications, 32
J. Bridgewater, P. Galle, Shahid Khan, J. Llovet, Joong-Won Park, Tushar Patel, T. Pawlik, G. Gores (2014)
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma.Journal of hepatology, 60 6
A. Cucchetti, A. Cappelli, G. Ercolani, C. Mosconi, M. Cescon, R. Golfieri, A. Pinna (2016)
Selective Internal Radiation Therapy (SIRT) as Conversion Therapy for Unresectable Primary Liver MalignanciesLiver Cancer, 5
F. Pardo, B. Sangro, R. Lee, D. Manas, R. Jeyarajah, V. Donckier, G. Maleux, A. Pinna, L. Bester, D. Morris, D. Iannitti, P. Chow, R. Stubbs, P. Gow, G. Masi, Kevin Fisher, W. Lau, K. Kouladouros, G. Katsanos, G. Ercolani, F. Rotellar, J. Bilbao, M. Schoen (2017)
The Post-SIR-Spheres Surgery Study (P4S): Retrospective Analysis of Safety Following Hepatic Resection or Transplantation in Patients Previously Treated with Selective Internal Radiation Therapy with Yttrium-90 Resin MicrospheresAnnals of Surgical Oncology, 24
H. Bourien, X. Palard, Y. Rolland, F. Du, L. Beuzit, T. Uguen, S. Sourd, M. Pracht, Vincent Manceau, A. Lièvre, K. Boudjema, E. Garin, J. Edeline (2018)
Yttrium-90 glass microspheres radioembolization (RE) for biliary tract cancer: a large single-center experienceEuropean Journal of Nuclear Medicine and Molecular Imaging, 46
B. Roy, M. Gelli, G. Pittau, M. Allard, B. Pereira, B. Serji, E. Vibert, D. Castaing, R. Adam, D. Cherqui, A. Cunha (2018)
Neoadjuvant chemotherapy for initially unresectable intrahepatic cholangiocarcinomaBritish Journal of Surgery, 105
Z. Jia, R. Paz-Fumagalli, G. Frey, D. Sella, J. McKinney, Weiping Wang (2017)
Resin-based Yttrium-90 microspheres for unresectable and failed first-line chemotherapy intrahepatic cholangiocarcinoma: preliminary resultsJournal of Cancer Research and Clinical Oncology, 143
J. Primrose, R. Fox, D. Palmer, H. Malik, R. Prasad, D. Mirza, A. Anthony, P. Corrie, S. Falk, M. Finch-Jones, H. Wasan, P. Ross, L. Wall, J. Wadsley, J. Evans, D. Stocken, R. Praseedom, Yuk Ma, B. Davidson, J. Neoptolemos, T. Iveson, J. Raftery, Shihua Zhu, D. Cunningham, O. Garden, C. Stubbs, J. Valle, J. Bridgewater (2019)
Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study.The Lancet. Oncology, 20 5
Peter Reimer, M. Virarkar, M. Binnenhei, M. Justinger, M. Schön, K. Tatsch (2018)
Prognostic Factors in Overall Survival of Patients with Unresectable Intrahepatic Cholangiocarcinoma Treated by Means of Yttrium-90 Radioembolization: Results in Therapy-Naïve PatientsCardioVascular and Interventional Radiology, 41
Nataliya Razumilava, Gregory Gores (2014)
CholangiocarcinomaThe Lancet, 383
R. Hoffmann, P. Paprottka, A. Schön, F. Bamberg, A. Haug, E. Dürr, B. Rauch, C. Trumm, T. Jakobs, T. Helmberger, M. Reiser, F. Kolligs (2012)
Transarterial Hepatic Yttrium-90 Radioembolization in Patients with Unresectable Intrahepatic Cholangiocarcinoma: Factors Associated with Prolonged SurvivalCardioVascular and Interventional Radiology, 35
A. Gangi, Jehan Shah, N. Hatfield, Johnna Smith, J. Sweeney, Junsung Choi, G. El-Haddad, B. Biebel, N. Parikh, B. Arslan, S. Hoffe, J. Frakes, G. Springett, D. Anaya, M. Malafa, Dung-tsa Chen, Yunyu Chen, R. Kim, R. Shridhar, B. Kis (2018)
Intrahepatic Cholangiocarcinoma Treated with Transarterial Yttrium-90 Glass Microsphere Radioembolization: Results of a Single Institution Retrospective Study.Journal of vascular and interventional radiology : JVIR, 29 8
J. Edeline, F. Du, M. Rayar, Y. Rolland, L. Beuzit, K. Boudjema, T. Rohou, M. Latournerie, B. Campillo-Gimenez, E. Garin, E. Boucher (2015)
Glass Microspheres 90Y Selective Internal Radiation Therapy and Chemotherapy as First-Line Treatment of Intrahepatic CholangiocarcinomaClinical Nuclear Medicine, 40
T. Okusaka, K. Nakachi, A. Fukutomi, N. Mizuno, S. Ohkawa, A. Funakoshi, M. Nagino, S. Kondo, S. Nagaoka, J. Funai, M. Koshiji, Y. Nambu, J. Furuse, M. Miyazaki, Y. Nimura (2010)
Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in JapanBritish Journal of Cancer, 103
Hypofractionated Proton Beam Therapy in Patients With Localized
M. Rayar, L. Sulpice, J. Edeline, E. Garin, G. Sandri, B. Meunier, E. Boucher, K. Boudjema (2015)
Intra-arterial Yttrium-90 Radioembolization Combined with Systemic Chemotherapy is a Promising Method for Downstaging Unresectable Huge Intrahepatic Cholangiocarcinoma to Surgical TreatmentAnnals of Surgical Oncology, 22
This phase 2 clinical trial measures the 3-month response rate of selective internal radiotherapy combined with chemotherapy as well as toxic effects, overall and progression-free survival, and disease control rate for patients with unresectable intrahepatic cholangiocarcinoma.
JAMA Oncology – American Medical Association
Published: Jan 31, 2020
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.